Cefotaxime in the prophylaxis of otorhinolaryngological cancer surgery. Long term versus short term administration, results of a multicentre study.
Gehanno
P
P
Service ORL, Hôpital Claude Bernard, Paris.
Moisy
N
N
Guédon
C
C
D000368:Aged; D002439:Cefotaxime / Q000627:therapeutic use*; D005260:Female; D005602:France; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010039:Otorhinolaryngologic Neoplasms / Q000150:complications / Q000601:surgery*; D011897:Random Allocation; D018805:Sepsis / Q000453:epidemiology; D013530:Surgical Wound Infection / Q000453:epidemiology / Q000517:prevention & control*; D013997:Time Factors
D002439:Cefotaxime